Taylor Sandison
2022
In 2022, Taylor Sandison earned a total compensation of $726.4K as Chief Medical Officer at Cidara Therapeutics, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $165,400 |
|---|---|
| Option Awards | $52,710 |
| Salary | $457,500 |
| Stock Awards | $41,635 |
| Other | $9,150 |
| Total | $726,395 |
Sandison received $457.5K in salary, accounting for 63% of the total pay in 2022.
Sandison also received $165.4K in non-equity incentive plan, $52.7K in option awards, $41.6K in stock awards and $9.2K in other compensation.
Rankings
In 2022, Taylor Sandison's compensation ranked 3,693rd out of 5,753 executives tracked by ExecPay. In other words, Sandison earned more than 35.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,693 out of 5,753 | 36th |
Division Manufacturing | 2,097 out of 3,133 | 33rd |
Major group Chemicals And Allied Products | 1,012 out of 1,419 | 29th |
Industry group Drugs | 949 out of 1,320 | 28th |
Industry Biological Products, Except Diagnostic Substances | 224 out of 291 | 23rd |
Source: SEC filing on April 27, 2023.
Sandison's colleagues
We found two more compensation records of executives who worked with Taylor Sandison at Cidara Therapeutics in 2022.
News
Cidara Therapeutics CEO Jeffrey Stein's 2023 pay jumps 24% to $1.6M
June 3, 2024
Cidara Therapeutics CEO Jeffrey Stein's 2022 pay falls 23% to $1.3M
April 27, 2023
Cidara Therapeutics CEO Jeffrey Stein's 2021 pay jumps 26% to $1.6M
April 29, 2022
Cidara Therapeutics CEO Jeffrey Stein's 2019 pay rises 6% to $1.5M
April 29, 2020
Cidara Therapeutics CEO Jeffrey Stein's 2018 pay falls 25% to $1.4M
April 26, 2019